Brown v. MacHeers

547 S.E.2d 759, 249 Ga. App. 418, 2001 Fulton County D. Rep. 1358, 2001 Ga. App. LEXIS 455
CourtCourt of Appeals of Georgia
DecidedApril 11, 2001
DocketA01A0019
StatusPublished
Cited by3 cases

This text of 547 S.E.2d 759 (Brown v. MacHeers) is published on Counsel Stack Legal Research, covering Court of Appeals of Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brown v. MacHeers, 547 S.E.2d 759, 249 Ga. App. 418, 2001 Fulton County D. Rep. 1358, 2001 Ga. App. LEXIS 455 (Ga. Ct. App. 2001).

Opinion

Phipps, Judge.

Lonnie Brown, individually and as administrator of his wife’s estate, brought this wrongful death and medical malpractice action against Dr. Steven Macheers. The jury returned a verdict in favor of Dr. Macheers. Brown contends in this appeal that the trial court erred or abused its discretion in various rulings concerning examination of witnesses, admission of evidence, and jury instructions. We agree and reverse.

Mrs. Brown was born with a ventricular septal heart defect which, in her childhood, necessitated an operation known as a sternotomy. As an adult, she required another sternotomy, which was performed by Dr. Macheers. Due to the serious nature of Mrs. Brown’s condition, complications arose during and after the operation, and she died from coagulopathy or excessive bleeding.

Evidence was presented showing that administration of the drugs Amicar or Aprotinin before surgery diminishes the risk of excessive bleeding, whereas ingestion of aspirin enhances such risk. Brown’s medical expert, Dr. Webb, testified that because repeat sternotomies are generally prolonged procedures, and particularly because Mrs. Brown had taken aspirin when she was catheterized near the time of her surgery, Dr. Macheers committed professional negligence by not giving her Amicar or Aprotinin before the operation. Dr. Macheers testified that Aprotinin was contraindicated in this case because one of the primary risks to Mrs. Brown was blood clotting, and administration of Aprotinin has been known to result in the formation of blood clots and to cause death. Dr. Macheers’s medical expert, Dr. Rosengart, testified that no applicable standard of care required Dr. Macheers to administer Amicar or Aprotinin in this case.

1. The trial court abused its discretion, Brown charges, by refusing to allow him to question Dr. Macheers about his reaction when Dr. Webb testified that Mrs. Brown had taken aspirin before her operation.

Brown maintains that Dr. Macheers registered surprise by hurriedly flipping through his papers when the question was asked, thereby indicating that he had not realized that she had taken the drug. Brown sought to question Dr. Macheers about his reaction, but counsel for Dr. Macheers objected. The court sustained the objection “as to drawing inferences from rattling papers.” The court should not have sustained the objection on that ground, because “ ‘the conduct of a party . . . with respect to the case is the subject of legitimate com *419 ment. . . .’ [Cit.]” 1

2. Brown contends that the court violated the fairness doctrine by refusing to require Dr. Macheers’s attorney to introduce all parts of Dr. Webb’s deposition relevant to a matter on which Dr. Webb was being impeached.

The fairness doctrine is based on OCGA § 9-11-32 (a) (5). In pertinent part, this statute provides that “[i]f only part of a deposition is offered in evidence by a party, an adverse party may require him to introduce all of it which is relevant to the part introduced, and any party may introduce any other parts.” This court, in Wells v. Aider- man, 2 held that “[f]airness demands that no less than all portions relevant to that interrogated about be introduced at the same time.” 3 The court in Wells explained that “[t]hese may fully explain any apparent conflict, or at least place' the witness in better position to reconcile or explain it,” and that “[a] statement out of context and without accompanying explanatory matter may be damaging and unfairly so.” 4 Consequently, Wells concluded that where the plaintiff was cross-examining a witness about a statement he had made in a deposition, the defendant could require the plaintiff to introduce other relevant parts of the deposition during cross-examination, even though the statute also permits the defendant’s later introduction of the other parts of the deposition.

While questioning Dr. Webb, Dr. Macheers’s attorney observed that in his deposition Dr. Webb had not criticized Dr. Macheers for failing to use Amicar or Aprotinin prophylactically. Dr. Webb responded that, at the time, he was not aware that Mrs. Brown had ingested aspirin and that, in light of the presence of aspirin in her system, Dr. Macheers should have given her Amicar or Aprotinin. Invoking the fairness doctrine, Brown’s attorney thereupon objected to counsel’s not reading other parts of Dr. Webb’s deposition during cross-examination. The court overruled the objection after Dr. Macheers’s attorney stated that Brown’s attorney could read other parts of the deposition on redirect examination. Under Wells, the court erred in so ruling.

3. Brown contends that the court abused its discretion by refusing to allow him to cross-examine Dr. Macheers about whether the cost of Aprotinin affected his decision not to administer it.

During his cross-examination of Dr. Kauten, who assisted Dr. Macheers in performing the operation, Brown’s attorney elicited tes *420 timony showing that one reason physicians do not make extensive use of Aprotinin is that it is an expensive drug, and there is a risk that health care plans will deny reimbursement. However, Dr. Kauten explained that the expense of the drug is borne by the patient or hospital and does not affect the physician’s fee. When Dr. Kauten testified that Aprotinin costs between $500 and $1,000 per patient, Brown’s attorney asked if that was too much to spend for a drug that might have saved Mrs. Brown’s life. Dr. Kauten responded in the affirmative, noting that effectiveness of the drug has not been proven.

Before Dr. Macheers testified, the trial court sustained defense counsel’s objection to Brown’s posing questions to Dr. Macheers concerning the expense of Aprotinin. The court ruled that the matter had been adequately covered during the cross-examination of Dr. Kauten and that questioning Dr. Macheers on the same subject would be repetitive. We cannot agree with this ruling. Cross-examination of Dr. Kauten concerning how the cost of the drug might have affected the defendant’s decision not to prescribe it did not adequately substitute for questioning the defendant himself. By refusing to permit Brown’s attorney to engage in any inquiry of Dr. Macheers on this highly relevant issue, the trial court committed a harmful abuse of discretion necessitating a reversal of the judgment.

4. Brown charges the court abused its discretion by refusing to allow him to establish bias on the part of Dr. Kauten by showing that in his deposition he was represented by the same attorneys who represented Dr. Macheers at trial.

The court ruled that Brown could adequately impeach Dr. Kauten for bias by showing that he and Dr. Macheers are partners in the same group practice. As Dr. Kauten’s relationship to Dr. Macheers was thereby proved, 5 the court did not abuse its discretion.

5.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lorrene Woods v. Shawn Heath
Court of Appeals of Georgia, 2024
West v. BREAST CARE SPECIALISTS, LLC
659 S.E.2d 895 (Court of Appeals of Georgia, 2008)
Dascombe v. Hanley
606 S.E.2d 602 (Court of Appeals of Georgia, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
547 S.E.2d 759, 249 Ga. App. 418, 2001 Fulton County D. Rep. 1358, 2001 Ga. App. LEXIS 455, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brown-v-macheers-gactapp-2001.